Correlation between Pentraxin 3 level and some biomarkers in Type 2 Diabetes mellitus Iraqi patients

Ali Muhammad Hasan, Hind Salman Jasim, Shatha Hamed Jwaid

Abstract


Background: Diabetes is a long-term metabolic disorder that has an impact on how your body utilizes glucose as an energy source. It can lead to a range of complications and damage to various organs in the body. These can include retinopathy. Diabetes Retinopathy (DR) is an eye-related complication of diabetes and is brought on by injury to the blood vessels feeding the retina. This can result in blindness.

Methods: The study had 100 T2DM patients and 50 healthy controls with an age range of 40 to 80 years, and a disease duration of 1 to 30 years. The participants were divided into two groups DR and DWR and the control group. The study ran from November 2022 to January 2023 in the governorates of Diyala and Bagdad.

Result: The mean levels of PTX3, Urea and FBG levels increase in the DR patients the statistical significance of these differences was very high (P>0.01). The patients' group also saw a highly significant rise in creatinine and a highly significant drop in GFR (P>0.01) when compared to the control.

Conclusion: PTX3 and FBG levels have been shown to be elevated in people with DR compared to controls and DWR, and these levels have been found to be connected with the onset and severity of DR. While there is no clear link between urea and retinopathy. More study is needed, though, to fully understand the mechanisms underlying this association and determine whether PTX3 can be a useful diagnostic or therapeutic target for DR.

Full Text:

PDF

References


Dawood AA, Kamel MA, Omar TA, Agaba AAM. Study of serum pentraxin 3 level in patients with diabetic nephropathy,” Egypt. Journal of Internal Medicine, (2020); 32(1): 1-9.

Perreault L, Skyler JS, Rosenstock J. Novel therapies with precision mechanisms for type 2 diabetes mellitus. Nature Reviews Endocrinology, (2021); 17(6): 364-377.

Chodkowski A, Nabrdalik K, Kwiendacz H, Tomasik A, Bartman W, Gumprecht J. Pentraxin 3 and retinopathy among type 2 diabetic patients in relation to carotid atherosclerosis and systolic and diastolic cardiac function — a Pilot study. Clinical Diabetology, (2018); 7(4): 196-202.

Srienc AI. Retinal Ischemia in the In Vivo Rodent: Cellular and Vascular Characteristics,” ProQuest Diss. Theses, no. September, p. 97, 2015, [Online]. Available: https://manchester.idm.oclc.org/login?url=https://search.proquest.com/docview/1990647870?accountid=12253%0Ahttp://man-fe.hosted.exlibrisgroup.com/openurl/44MAN/44MAN_services_page?genre=dissertations+%26+theses&atitle=&author=Srienc%2C+Anja+Iwona&volume=&

Vujosevic S, Aldington SJ, Silva P, Hernández C, Scanlon P, Peto T, Simó R. Screening for diabetic retinopathy: new perspectives and challenges. The Lancet Diabetes & Endocrinology, (2020); 8(4): 337-47.

Zhang H, Wang R, Wang Z, Wu W, Zhang N, Zhang L, Hu J, Luo P, Zhang J, Liu Z, Feng S. Molecular insight into pentraxin-3: Update advances in innate immunity, inflammation, tissue remodeling, diseases, and drug role. Biomedicine & Pharmacotherapy, (2022); 30: 113783.

Porte R, Davoudian S, Asgari F, Parente R, Mantovani A, Garlanda C, Bottazzi B. The long pentraxin PTX3 as a humoral innate immunity functional player and biomarker of infections and sepsis. Frontiers in Immunology, (2019); 12(10): 794.

Fahey E, Doyle SL. IL-1 family cytokine regulation of vascular permeability and angiogenesis. Frontiers in Immunology, (2019); 25(10): 1426.

Yaseen YO, Atyia JJ. Facts about type 2 diabetes mellitus and its control in Misan Governorate. Single-center experience. The medical journal of Basrah university, (2018); 36(2): 81-6.

Annani-Akollor ME, Addai-Mensah O, Fondjo LA, Sallah L, Owiredu EW, Acheampong E, Akamugri S. Predominant complications of type 2 diabetes in kumasi: a 4-year retrospective cross-sectional study at a teaching hospital in Ghana. Medicina, (2019); 55(5): 125.

Karatas S, Yesim T, Beysel S. Impact of lockdown COVID-19 on metabolic control in type 2 diabetes mellitus and healthy people. Primary care diabetes, (2021); 15(3): 424-7.

Yuan X, Wang J, Yang S, Gao M, Cao L, Li X, Hong D, Tian S, Sun C. Effect of the ketogenic diet on glycemic control, insulin resistance, and lipid metabolism in patients with T2DM: a systematic review and meta-analysis. Nutrition & diabetes, (2020); 10(1): 38.

Takele MB, Boneya DJ, Alemu HA, Tsegaye TB, Birhanu MY, Alemu S, Anto TG. Retinopathy among Adult Diabetics and Its Predictors in Northwest Ethiopia. Journal of Diabetes Research, (2022); 1362144.

Sullivan KM, Scholey J, Moineddin R, Sochett E, Wicklow B, Elia Y, Xiao F, Mederios T, Sadi P, Burger D, Mahmud FH. Urinary podocyte-derived microparticles in youth with type 1 and type 2 diabetes. Diabetologia, (2021); 64: 469-75.

Sugondo AT, Nuswantoro D, Notopuro PB, Ardiany D. Relationship between HbA1c levels with eGFR and blood pressure in type 2 diabetes mellitus patients at general hospital in Surabaya. Biomolecular and Health Science Journal, (2019); 2(2): 117-20.

Babaliche P, Nadpara RA, Maldar A. Association between estimated glomerular filtration rate and microvascular complications in type II diabetes mellitus patients: a 1-year cross-sectional study. Journal of the National Medical Association, (2019); 111(1): 83-7.

Zhuang X, Cao D, Yang D, Zeng Y, Yu H, Wang J, Kuang J, Xie J, Zhang S, Zhang L. Association of diabetic retinopathy and diabetic macular oedema with renal function in southern Chinese patients with type 2 diabetes mellitus: a single-centre observational study. BMJ open, (2019); 9(9): e031194.

Dawood AA, Kamel MA, Omar TA, Agaba AA. Study of serum pentraxin 3 level in patients with diabetic nephropathy. The Egyptian Journal of Internal Medicine, (2020); 32(1): 1-9.

Kocak MZ, Aktas G, Erkus E, Sincer I, Atak B, Duman T. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Revista da Associação Médica Brasileira, (2019); 65: 9-15.

Azzal HS, Majeed MJ, dyab Allawi AA, Hammoudi FA. CORRELATION OF SOLUBLE KLOTHO WITH PROGRESS STAGES OF DIABETIC NEPHROPATHY. Biochemical & Cellular Archives, (2021); 21(1): 1585-1588

Azzall HS, Majeed MJ, dyab Allawi AA, Hammoudi FA. Correlation of Fibroblast growth factor (FGF23) with progress stages of diabetic nephropathy. International Medical Journal, (2020); 25(7): 2809-2814.

Tomita Y, Cagnone G, Fu Z, Cakir B, Kotoda Y, Asakage M, Wakabayashi Y, Hellström A, Joyal JS, Talukdar S, Smith LE. Vitreous metabolomics profiling of proliferative diabetic retinopathy. Diabetologia, (2021); 64: 70-82.

Hameed YA, Muraih JK. Detection of biochemical causes the diabetic retinopathy in diabetes (Type ii) patients in al-muthanna province. Indian Journal of Forensic Medicine & Toxicology, (2021); 15(1): 2569-74.

Wang M, Tan Y, Shi Y, Wang X, Liao Z, Wei P. Diabetes and Sarcopenic obesity: pathogenesis, diagnosis, and treatments. Frontiers in Endocrinology (Lausanne), (2020); 11: 568.

Huang Q, Wu H, Wo M, Ma J, Song Y, Fei X. Clinical and predictive significance of Plasma Fibrinogen Concentrations combined Monocyte-lymphocyte ratio in patients with Diabetic Retinopathy. International Journal of Medical Sciences, (2021); 18(6): 1390.

Li T, Wu Y. Correlation of Glucose and Lipid Metabolism Levels and Serum Uric Acid Levels with Diabetic Retinopathy in Type 2 Diabetic Mellitus Patients. Emergency Medicine International, (2022); 9201566

Jabbar TL, Kasim AA. Association of retinol binding protein-4 (RBP4) with glycemia, dyslipidemia, hypertension, and obesity in type 2 diabetic Iraqi patients. Iraqi Journal of Pharmaceutical Sciences, (2020); 29(2): 263-70.

Reid LJ, Gibb FW, Colhoun H, Wild SH, Strachan MW, Madill K, Dhillon B, Forbes S. Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin. Diabetologia, (2021); 64(8): 1725-36.

Sultan NS, AL-Tai AF. Estimation of pentraxin-3 (PTX3) in Rheumatoid arthritis males patients with (with and without) type II diabetes mellitus in Iraq. Ibn AL-Haitham Journal for Pure and Applied Sciences, (2018); 31(3): 55-62.

Stravalaci M, Ferrara M, Pathak V, Davi F, Bottazzi B, Mantovani A, Medina RJ, Romano MR, Inforzato A. The long pentraxin ptx3 as a new biomarker and pharmacological target in age-related macular degeneration and diabetic retinopathy. Frontiers in Pharmacology, (2022); 12: 3975.

Takashi Y, Koga M, Matsuzawa Y, Saito J, Omura M, Nishikawa T. Circulating pentraxin 3 is positively associated with chronic hyperglycemia but negatively associated with plasma aldosterone concentration. PloS one, (2018); 13(5): e0196526.


Refbacks

  • There are currently no refbacks.